LORIUM · 1 mg LYOPHILISED VIALIGF-1 LR3
IGF-1 LR3 is a highly potent synthetic analogue of human insulin-like growth factor-1, engineered with an Arginine substitution and an extended peptide sequence. By dramatically reducing binding to inhibitory transport proteins and maximizing receptor affinity, this advanced protocol triggers sustained activation of anabolic pathways to drive deep tissue repair and hyperplasia.
Researched effects
Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.
Lean Muscle Growth
Increases long-term lean body mass via satellite cell proliferation.
Advanced Tissue Repair
Accelerates deep recovery of muscles, tendons, and ligaments.
Enhanced Protein Synthesis
Maximizes baseline anabolic processes for rapid physical renewal.
Pathway Activation
Strongly stimulates the central PI3K/Akt/mTOR anabolic pathways.
Hyperplasia Support
Drives cellular proliferation in muscles, tendons, and ligaments.
Optimized Fat Metabolism
Improves cellular glucose utilization and supports fat oxidation.
Structural Bone Health
Promotes long-term bone mineral density and skeletal tissue strength.
Specifications
Clinical references
- Frost, R. A., & Lang, C. H. (2007). Regulation of IGF-1 and Skeletal Muscle Growth. Growth Horm IGF Res, 17(5).
- Barton-Davis, E. R., et al. (1999). IGF-1 LR3 Increases Muscle Mass and Strength. J Clin Invest, 103(2).
- Roh, J. D., et al. (2009). IGF-1 Promotes Vascular Repair and Endothelial Function. Mol Ther, 17(9).
- Clemmons, D. R. (2007). Role of IGF-1 in Growth and Metabolism. J Clin Endocrinol Metab, 92(4).
More in Growth

CJC-1295 (no DAC)
A GHRH analogue that selectively stimulates the anterior pituitary to increase growth hormone and IGF-1 while preserving natural pulsatile release.

CJC-1295 DAC
An advanced GHRH analogue with a Drug Affinity Complex that binds serum albumin to extend its half-life to nearly a week for sustained GH and IGF-1 stimulation.

Ipamorelin
A highly selective synthetic pentapeptide growth hormone secretagogue that stimulates pituitary GH release via the GHS-R1a receptor without disrupting other endocrine pathways.